Study Shows Few Clinicians Prescribe Buprenorphine to Patients With Opioid Use Disorder
Brian Skinner
Health Care, Substance Use Prevention and Treatment
Pew – By Alexandra Duncan & Ian Reynolds – August 24, 2020
Research published Aug. 24 in JAMA Network Open helps to explain the vast treatment gap for people with opioid use disorder (OUD), attributing it in part to the small number of clinicians prescribing buprenorphine, a Food and Drug Administration (FDA)-approved medication that has been proved effective. More than 2 million Americans have OUD, but only about 26% receive any kind of treatment.